| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |